Literature DB >> 29432714

Suppressive effects of aryl-hydrocarbon receptor repressor on adipocyte differentiation in 3T3-L1 cells.

Yasuhiro Ishihara1, Mayumi Tsuji2, Christoph F A Vogel3.   

Abstract

The aryl-hydrocarbon receptor repressor (AhRR) negatively regulates aryl-hydrocarbon receptor (AhR) signaling via its inhibitory transactivation. AhR is well known to suppress adipocyte differentiation, but the function of AhRR during adipogenesis is unclear. The purpose of this study was to investigate the role of AhRR in adipocyte differentiation using 3T3-L1 cells. During the early phase of differentiation, AhRR expression was transiently induced, but throughout the entire differentiation process, low levels of AhR expression were maintained. AhRR knockdown significantly increased not only glycerol-3-phosphate dehydrogenase (GPDH) activity but also lipid accumulation inside the cells. AhRR overexpression clearly reduced GPDH activity and lipid accumulation, indicating that AhRR upregulation during the early stage of adipogenesis suppresses adipocyte differentiation. Since AhRR knockdown increases the expression and activity of peroxisome proliferator-activated receptor γ (PPARγ), AhRR negatively regulates PPARγ during adipogenesis. In summary, similar to AhR, AhRR acts as an inhibitor of adipocyte differentiation. In addition to controlling the negative feedback loop of AhR, AhRR might be involved in other functions, especially in adipocyte differentiation processes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29432714      PMCID: PMC5962015          DOI: 10.1016/j.abb.2018.01.018

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  30 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

2.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.

Authors:  J V Schmidt; G H Su; J K Reddy; M C Simon; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 3.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Immunol       Date:  2006-09-22       Impact factor: 53.106

Review 4.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

5.  Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.

Authors:  P C Liu; M A Phillips; F Matsumura
Journal:  Mol Pharmacol       Date:  1996-06       Impact factor: 4.436

6.  Dual role of superoxide dismutase 2 induced in activated microglia: oxidative stress tolerance and convergence of inflammatory responses.

Authors:  Yasuhiro Ishihara; Takuya Takemoto; Kouichi Itoh; Atsuhiko Ishida; Takeshi Yamazaki
Journal:  J Biol Chem       Date:  2015-07-31       Impact factor: 5.157

Review 7.  The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver.

Authors:  Karl Walter Bock; Christoph Köhle
Journal:  Biol Chem       Date:  2009-12       Impact factor: 3.915

8.  Beta-mecaptoethanol suppresses inflammation and induces adipogenic differentiation in 3T3-F442A murine preadipocytes.

Authors:  Wen Guo; Yahui Li; Wentao Liang; Siu Wong; Caroline Apovian; James L Kirkland; Barbara E Corkey
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Long noncoding RNA LINC00305 promotes inflammation by activating the AHRR-NF-κB pathway in human monocytes.

Authors:  Dan-Dan Zhang; Wen-Tian Wang; Jian Xiong; Xue-Min Xie; Shen-Shen Cui; Zhi-Guo Zhao; Mulin Jun Li; Zhu-Qin Zhang; De-Long Hao; Xiang Zhao; Yong-Jun Li; Junwen Wang; Hou-Zao Chen; Xiang Lv; De-Pei Liu
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

10.  Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis.

Authors:  D L Alexander; L G Ganem; P Fernandez-Salguero; F Gonzalez; C R Jefcoate
Journal:  J Cell Sci       Date:  1998-11       Impact factor: 5.285

View more
  4 in total

1.  Tributyltin disrupts fin development in Fundulus heteroclitus from both PCB-sensitive and resistant populations: Investigations of potential interactions between AHR and PPARγ.

Authors:  K A Crawford; B W Clark; W J Heiger-Bernays; S I Karchner; M E Hahn; D E Nacci; J J Schlezinger
Journal:  Aquat Toxicol       Date:  2019-11-11       Impact factor: 4.964

2.  Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation.

Authors:  Won-Bhin Hwang; Da-Jeong Kim; Gap-Soo Oh; Joo-Hung Park
Journal:  Immune Netw       Date:  2018-10-23       Impact factor: 6.303

Review 3.  Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition.

Authors:  Yan Li; Carol A Pollock; Sonia Saad
Journal:  Genes (Basel)       Date:  2021-10-20       Impact factor: 4.096

4.  Integrative Analysis Between Genome-Wide Association Study and Expression Quantitative Trait Loci Reveals Bovine Muscle Gene Expression Regulatory Polymorphisms Associated With Intramuscular Fat and Backfat Thickness.

Authors:  Bárbara Silva-Vignato; Aline Silva Mello Cesar; Juliana Afonso; Gabriel Costa Monteiro Moreira; Mirele Daiana Poleti; Juliana Petrini; Ingrid Soares Garcia; Luan Gaspar Clemente; Gerson Barreto Mourão; Luciana Correia de Almeida Regitano; Luiz Lehmann Coutinho
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.